O	O	0	9	Induction	Induction	B-NP	NN	O	0	ROOT	O
O	O	10	12	of	of	B-PP	IN	O	1	NMOD	O
O	O	13	21	cytokine	cytokine	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	22	32	expression	expression	I-NP	NN	O	2	PMOD	O
O	O	33	35	in	in	B-PP	IN	O	1	NMOD	O
O	O	36	46	leukocytes	leukocyte	B-NP	NNS	B-cell_type	5	PMOD	B-cell_type
O	O	47	49	by	by	B-PP	IN	O	1	NMOD	O
O	O	50	57	binding	binding	B-NP	NN	O	7	PMOD	O
O	O	58	60	of	of	B-PP	IN	O	8	NMOD	O
O	O	61	69	thrombin	thrombin	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	69	70	-	-	B-NP	HYPH	O	13	P	O
O	O	70	80	stimulated	stimulate	I-NP	VBN	B-cell_type	13	NMOD	B-cell_type
O	O	81	90	platelets	platelet	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	90	91	.	.	O	.	O	1	P	O

O	O	93	103	BACKGROUND	BACKGROUND	B-NP	NN	O	0	ROOT	O
O	O	103	104	:	:	O	:	O	1	P	O
O	O	105	114	Activated	Activate	B-NP	VBN	B-cell_type	4	NMOD	B-cell_type
O	O	115	124	platelets	platelet	I-NP	NNS	I-cell_type	5	SUB	I-cell_type
O	O	125	131	tether	tether	B-VP	VBP	O	1	NMOD	O
O	O	132	135	and	and	I-VP	CC	O	5	VMOD	O
O	O	136	144	activate	activate	I-VP	VBP	O	5	VMOD	O
O	O	145	152	myeloid	myeloid	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	153	163	leukocytes	leukocyte	I-NP	NNS	I-cell_type	5	VMOD	I-cell_type
O	O	163	164	.	.	O	.	O	5	P	O

O	O	165	167	To	To	B-VP	TO	O	2	VMOD	O
O	O	168	179	investigate	investigate	I-VP	VB	O	18	VMOD	O
O	O	180	183	the	the	B-NP	DT	O	5	NMOD	O
O	O	184	193	potential	potential	I-NP	JJ	O	5	NMOD	O
O	O	194	203	relevance	relevance	I-NP	NN	O	2	OBJ	O
O	O	204	206	of	of	B-PP	IN	O	5	NMOD	O
O	O	207	211	this	this	B-NP	DT	O	8	NMOD	O
O	O	212	221	mechanism	mechanism	I-NP	NN	O	6	PMOD	O
O	O	222	224	in	in	B-PP	IN	O	8	NMOD	O
O	O	225	230	acute	acute	B-NP	JJ	O	12	NMOD	O
O	O	231	241	myocardial	myocardial	I-NP	JJ	O	12	NMOD	O
O	O	242	252	infarction	infarction	I-NP	NN	O	9	PMOD	O
O	O	253	254	(	(	O	(	O	15	DEP	O
O	O	254	257	AMI	AMI	B-NP	NN	B-protein	15	DEP	B-protein
O	O	257	258	)	)	O	)	O	12	NMOD	O
O	O	258	259	,	,	O	,	O	18	P	O
O	O	260	262	we	we	B-NP	PRP	O	18	SUB	O
O	O	263	271	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	272	280	cytokine	cytokine	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	281	290	induction	induction	I-NP	NN	O	28	NMOD	O
O	O	291	293	by	by	B-PP	IN	O	20	NMOD	O
O	O	294	303	leukocyte	leukocyte	B-NP	NN	B-cell_type	25	NMOD	B-cell_type
O	O	303	304	-	-	I-NP	HYPH	O	25	NMOD	O
O	O	304	312	platelet	platelet	I-NP	NN	O	25	NMOD	O
O	O	313	321	adhesion	adhesion	I-NP	NN	O	21	PMOD	O
O	O	322	325	and	and	O	CC	O	28	NMOD	O
O	O	326	329	the	the	B-NP	DT	O	28	NMOD	O
O	O	330	340	occurrence	occurrence	I-NP	NN	O	18	OBJ	O
O	O	341	343	of	of	B-PP	IN	O	28	NMOD	O
O	O	344	353	leukocyte	leukocyte	B-NP	NN	B-cell_type	33	NMOD	B-cell_type
O	O	353	354	-	-	B-NP	HYPH	O	33	NMOD	O
O	O	354	362	platelet	platelet	I-NP	NN	O	33	NMOD	O
O	O	363	373	conjugates	conjugate	I-NP	NNS	O	29	PMOD	O
O	O	374	376	in	in	B-PP	IN	O	18	VMOD	O
O	O	377	385	patients	patient	B-NP	NNS	O	34	PMOD	O
O	O	386	390	with	with	B-PP	IN	O	35	NMOD	O
O	O	391	394	AMI	AMI	B-NP	NN	O	36	PMOD	O
O	O	394	395	.	.	O	.	O	18	P	O

O	O	396	403	METHODS	METHODS	B-NP	NNS	O	3	NMOD	O
O	O	404	407	AND	AND	I-NP	CC	O	3	NMOD	O
O	O	408	415	RESULTS	RESULTS	I-NP	NNS	O	0	ROOT	O
O	O	415	416	:	:	O	:	O	3	P	O
O	O	417	419	We	We	B-NP	PRP	O	3	NMOD	O
O	O	420	428	obtained	obtain	B-VP	VBD	O	5	SBAR	O
O	O	429	439	peripheral	peripheral	B-NP	JJ	O	10	NMOD	O
O	O	440	446	venous	venous	I-NP	JJ	O	10	NMOD	O
O	O	447	452	blood	blood	I-NP	NN	O	10	NMOD	O
O	O	453	460	samples	sample	I-NP	NNS	O	6	OBJ	O
O	O	461	463	in	in	B-PP	IN	O	6	VMOD	O
O	O	464	466	20	20	B-NP	CD	O	13	NMOD	O
O	O	467	475	patients	patient	I-NP	NNS	O	11	PMOD	O
O	O	476	480	with	with	B-PP	IN	O	13	NMOD	O
O	O	481	484	AMI	AMI	B-NP	NN	O	14	PMOD	O
O	O	485	491	before	before	B-PP	IN	O	13	NMOD	O
O	O	492	495	and	and	O	CC	O	16	PMOD	O
O	O	496	501	daily	daily	B-ADVP	RB	O	19	PMOD	O
O	O	502	505	for	for	B-PP	IN	O	16	PMOD	O
O	O	506	507	5	5	B-NP	CD	O	21	NMOD	O
O	O	508	512	days	day	I-NP	NNS	O	19	PMOD	O
O	O	513	518	after	after	B-PP	IN	O	21	NMOD	O
O	O	519	525	direct	direct	B-NP	JJ	O	27	NMOD	O
O	O	526	538	percutaneous	percutaneous	I-NP	JJ	O	27	NMOD	O
O	O	539	551	transluminal	transluminal	I-NP	JJ	O	27	NMOD	O
O	O	552	560	coronary	coronary	I-NP	JJ	O	27	NMOD	O
O	O	561	572	angioplasty	angioplasty	I-NP	NN	O	22	PMOD	O
O	O	573	574	(	(	O	(	O	30	DEP	O
O	O	574	578	PTCA	PTCA	B-NP	NN	B-protein	30	DEP	B-protein
O	O	578	579	)	)	O	)	O	27	NMOD	O
O	O	580	583	and	and	O	CC	O	11	PMOD	O
O	O	584	586	in	in	B-PP	IN	O	11	PMOD	O
O	O	587	589	20	20	B-NP	CD	O	34	NMOD	O
O	O	590	598	patients	patient	I-NP	NNS	O	32	PMOD	O
O	O	599	609	undergoing	undergo	B-VP	VBG	O	34	NMOD	O
O	O	610	618	elective	elective	B-NP	JJ	O	37	NMOD	O
O	O	619	623	PTCA	PTCA	I-NP	NN	O	35	OBJ	O
O	O	623	624	.	.	O	.	O	3	P	O

O	O	625	635	Throughout	Throughout	B-PP	IN	O	14	VMOD	O
O	O	636	639	the	the	B-NP	DT	O	4	NMOD	O
O	O	640	645	study	study	I-NP	NN	O	4	NMOD	O
O	O	646	652	period	period	I-NP	NN	O	1	PMOD	O
O	O	652	653	,	,	O	,	O	14	P	O
T1	B-Protein	654	658	CD41	CD41	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	659	677	immunofluorescence	immunofluorescence	I-NP	NN	O	14	SUB	O
O	O	678	680	of	of	B-PP	IN	O	7	NMOD	O
O	O	681	691	leukocytes	leukocyte	B-NP	NNS	B-cell_type	8	PMOD	B-cell_type
O	O	692	693	(	(	O	(	O	13	DEP	O
O	O	693	697	flow	flow	B-NP	NN	O	12	NMOD	O
O	O	698	707	cytometry	cytometry	I-NP	NN	O	13	DEP	O
O	O	707	708	)	)	O	)	O	7	NMOD	O
O	O	709	717	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	718	727	increased	increase	B-NP	VBN	O	19	NMOD	O
O	O	728	737	leukocyte	leukocyte	I-NP	NN	B-cell_type	19	NMOD	B-cell_type
O	O	737	738	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	738	746	platelet	platelet	I-NP	NN	O	19	NMOD	O
O	O	747	755	adhesion	adhesion	I-NP	NN	O	14	OBJ	O
O	O	756	758	in	in	B-PP	IN	O	19	NMOD	O
O	O	759	767	patients	patient	B-NP	NNS	O	20	PMOD	O
O	O	768	772	with	with	B-PP	IN	O	21	NMOD	O
O	O	773	776	AMI	AMI	B-NP	NN	O	22	PMOD	O
O	O	777	785	compared	compare	B-PP	VBN	O	19	NMOD	O
O	O	786	790	with	with	B-PP	IN	O	24	PMOD	O
O	O	791	798	control	control	B-NP	NN	O	27	NMOD	O
O	O	799	807	patients	patient	I-NP	NNS	O	25	PMOD	O
O	O	808	809	(	(	O	(	O	58	DEP	O
O	O	809	813	mean	mean	B-NP	NN	O	54	AMOD	O
O	O	814	815	+	+	O	SYM	O	29	NMOD	O
O	O	815	816	/	/	O	SYM	O	30	SBAR	O
O	O	816	817	-	-	O	HYPH	O	31	SBAR	O
O	O	818	820	SE	SE	B-NP	NN	B-protein	32	NMOD	B-protein
O	O	821	823	of	of	B-PP	IN	O	33	NMOD	O
O	O	824	836	fluorescence	fluorescence	B-NP	NN	O	34	PMOD	O
O	O	837	838	[	[	O	(	O	38	DEP	O
O	O	838	846	channels	channel	B-NP	NNS	O	38	DEP	O
O	O	846	847	]	]	O	)	O	33	NMOD	O
O	O	848	854	before	before	B-PP	IN	O	32	VMOD	O
O	O	855	859	PTCA	PTCA	B-NP	NN	O	39	PMOD	O
O	O	859	860	:	:	O	:	O	29	P	O
O	O	861	863	77	77	B-NP	CD	O	54	AMOD	O
O	O	864	865	+	+	O	SYM	O	54	AMOD	O
O	O	865	866	/	/	O	SYM	O	54	P	O
O	O	866	867	-	-	B-NP	SYM	O	52	NMOD	O
O	O	868	870	16	16	B-NP	CD	O	52	NMOD	O
O	O	871	877	versus	versus	I-NP	IN	O	52	NMOD	O
O	O	878	880	35	35	I-NP	CD	O	52	NMOD	O
O	O	881	882	+	+	O	SYM	O	52	NMOD	O
O	O	882	883	/	/	B-NP	SYM	O	52	SUB	O
O	O	883	884	-	-	B-PP	SYM	O	52	VMOD	O
O	O	885	886	9	9	B-NP	CD	O	54	NMOD	O
O	O	886	887	;	;	O	:	O	54	P	O
O	O	888	889	P	P	B-NP	NN	O	55	SUB	O
O	O	890	891	=	=	I-NP	JJ	O	58	DEP	O
O	O	892	893	.	.	I-NP	.	O	55	P	O
O	O	893	896	003	003	I-NP	CD	O	55	AMOD	O
O	O	896	897	)	)	O	)	O	27	NMOD	O
O	O	897	898	.	.	O	.	O	14	P	O

O	O	899	901	In	In	B-ADVP	FW	O	9	VMOD	O
O	O	902	907	vitro	vitro	I-ADVP	FW	O	1	AMOD	O
O	O	907	908	,	,	O	,	O	9	P	O
T2	B-Protein	909	917	thrombin	thrombin	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	917	918	-	-	B-VP	HYPH	O	8	P	O
O	O	918	928	stimulated	stimulate	B-NP	VBN	B-cell_type	8	NMOD	B-cell_type
O	O	929	934	fixed	fix	I-NP	VBN	I-cell_type	8	NMOD	I-cell_type
O	O	935	944	platelets	platelet	I-NP	NNS	I-cell_type	9	SUB	I-cell_type
O	O	945	950	bound	bind	B-VP	VBD	O	0	ROOT	O
O	O	951	953	to	to	B-PP	TO	O	9	VMOD	O
O	O	954	965	neutrophils	neutrophil	B-NP	NNS	B-cell_type	13	NMOD	B-cell_type
O	O	966	969	and	and	I-NP	CC	O	13	NMOD	O
O	O	970	979	monocytes	monocyte	I-NP	NNS	B-cell_type	10	PMOD	B-cell_type
O	O	979	980	.	.	O	.	O	9	P	O

O	O	981	987	Within	Within	B-PP	IN	O	6	VMOD	O
O	O	988	989	2	2	B-NP	CD	O	3	NMOD	O
O	O	990	995	hours	hour	I-NP	NNS	O	1	PMOD	O
O	O	995	996	,	,	O	,	O	6	P	O
O	O	997	1001	this	this	B-NP	DT	O	6	SUB	O
O	O	1002	1010	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	1011	1013	in	in	B-PP	IN	O	6	VMOD	O
O	O	1014	1023	increased	increase	B-NP	VBN	O	9	NMOD	O
O	O	1024	1028	mRNA	mRNA	I-NP	NN	B-RNA	28	NMOD	B-RNA
O	O	1029	1032	for	for	B-PP	IN	O	9	NMOD	O
T3	B-Protein	1033	1044	interleukin	interleukin	B-NP	NN	B-protein	17	NMOD	B-protein
T3	I-Protein	1045	1046	(	(	O	(	I-protein	17	NMOD	I-protein
T3	I-Protein	1046	1048	IL	IL	B-NP	NN	I-protein	17	NMOD	I-protein
T3	I-Protein	1048	1049	)	)	O	)	I-protein	17	NMOD	I-protein
T3	I-Protein	1049	1050	,	,	O	,	I-protein	17	P	I-protein
T3	I-Protein	1050	1051	1	1	B-NP	CD	I-protein	17	NMOD	I-protein
T3	I-Protein	1052	1056	beta	beta	B-NP	SYM	I-protein	20	NMOD	I-protein
O	O	1056	1057	,	,	O	,	O	20	P	O
T4	B-Protein	1058	1060	IL	IL	B-NP	NN	B-protein	20	NMOD	B-protein
T4	I-Protein	1060	1061	-	-	O	HYPH	I-protein	10	SBAR	I-protein
T4	I-Protein	1061	1062	8	8	B-NP	CD	I-protein	20	NMOD	I-protein
O	O	1062	1063	,	,	O	,	O	28	P	O
O	O	1064	1067	and	and	O	CC	O	28	NMOD	O
T5	B-Protein	1068	1076	monocyte	monocyte	B-NP	NN	B-protein	28	NMOD	B-protein
T5	I-Protein	1077	1092	chemoattractant	chemoattractant	I-NP	NN	I-protein	28	NMOD	I-protein
T5	I-Protein	1093	1100	protein	protein	I-NP	NN	I-protein	28	NMOD	I-protein
T5	I-Protein	1101	1102	(	(	O	(	I-protein	28	NMOD	I-protein
T5	I-Protein	1102	1105	MCP	MCP	B-NP	NN	I-protein	7	PMOD	I-protein
T5	I-Protein	1105	1106	)	)	O	)	I-protein	28	NMOD	I-protein
T5	I-Protein	1106	1107	-	-	B-NP	HYPH	I-protein	28	P	I-protein
T5	I-Protein	1107	1108	1	1	I-NP	CD	I-protein	28	NMOD	I-protein
O	O	1109	1111	in	in	B-PP	IN	O	28	NMOD	O
O	O	1112	1126	unfractionated	unfractionated	B-NP	JJ	B-cell_type	34	NMOD	B-cell_type
O	O	1127	1137	leukocytes	leukocyte	I-NP	NNS	I-cell_type	32	PMOD	I-cell_type
O	O	1137	1138	.	.	O	.	O	6	P	O

O	O	1139	1144	After	After	B-PP	IN	O	20	VMOD	O
O	O	1145	1146	4	4	B-NP	CD	O	3	NMOD	O
O	O	1147	1152	hours	hour	I-NP	NNS	O	1	PMOD	O
O	O	1152	1153	,	,	O	,	O	20	P	O
T6	B-Protein	1154	1156	IL	IL	B-NP	NN	B-protein	8	NMOD	B-protein
T6	I-Protein	1156	1157	-	-	O	HYPH	I-protein	8	P	I-protein
T6	I-Protein	1157	1158	1	1	B-NP	CD	I-protein	8	NMOD	I-protein
T6	I-Protein	1159	1163	beta	beta	I-NP	SYM	I-protein	13	NMOD	I-protein
O	O	1164	1167	and	and	I-NP	CC	O	13	NMOD	O
T7	B-Protein	1168	1170	IL	IL	I-NP	NN	B-protein	13	NMOD	B-protein
T7	I-Protein	1170	1171	-	-	I-NP	HYPH	I-protein	13	NMOD	I-protein
T7	I-Protein	1171	1172	8	8	I-NP	CD	I-protein	13	NMOD	I-protein
O	O	1173	1186	concentration	concentration	I-NP	NN	O	20	SUB	O
O	O	1187	1189	of	of	B-PP	IN	O	13	NMOD	O
O	O	1190	1193	the	the	B-NP	DT	O	19	NMOD	O
O	O	1194	1198	cell	cell	I-NP	NN	O	19	NMOD	O
O	O	1198	1199	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	1199	1203	free	free	I-NP	JJ	O	19	NMOD	O
O	O	1204	1215	supernatant	supernatant	I-NP	NN	O	14	PMOD	O
O	O	1216	1219	had	have	B-VP	VBD	O	0	ROOT	O
O	O	1220	1229	increased	increase	I-VP	VBN	O	20	VC	O
O	O	1230	1232	by	by	B-PP	IN	O	45	VMOD	O
O	O	1233	1236	268	268	B-NP	CD	O	28	NMOD	O
O	O	1237	1238	+	+	O	SYM	O	28	NMOD	O
O	O	1238	1239	/	/	O	SYM	O	28	NMOD	O
O	O	1239	1240	-	-	O	SYM	O	28	NMOD	O
O	O	1241	1243	36	36	B-NP	CD	O	28	NMOD	O
O	O	1243	1244	%	%	I-NP	NN	O	35	NMOD	O
O	O	1245	1248	and	and	O	CC	O	35	NMOD	O
O	O	1249	1252	210	210	B-NP	CD	O	35	NMOD	O
O	O	1253	1254	+	+	O	SYM	O	35	NMOD	O
O	O	1254	1255	/	/	O	SYM	O	35	NMOD	O
O	O	1255	1256	-	-	O	SYM	O	35	NMOD	O
O	O	1257	1258	7	7	B-NP	CD	O	35	NMOD	O
O	O	1258	1259	%	%	I-NP	NN	O	22	PMOD	O
O	O	1259	1260	,	,	O	,	O	35	P	O
O	O	1261	1273	respectively	respectively	B-ADVP	RB	O	35	NMOD	O
O	O	1273	1274	,	,	O	,	O	22	P	O
O	O	1275	1278	and	and	O	CC	O	45	VMOD	O
O	O	1279	1287	cellular	cellular	B-NP	JJ	O	44	NMOD	O
T8	B-Protein	1288	1291	MCP	MCP	I-NP	NN	B-protein	44	NMOD	B-protein
T8	I-Protein	1291	1292	-	-	B-NP	HYPH	I-protein	44	NMOD	I-protein
T8	I-Protein	1292	1293	1	1	I-NP	CD	I-protein	44	NMOD	I-protein
O	O	1294	1301	content	content	I-NP	NN	O	45	SUB	O
O	O	1302	1305	had	have	B-VP	VBD	O	21	VMOD	O
O	O	1306	1315	increased	increase	I-VP	VBN	O	45	VC	O
O	O	1316	1318	by	by	B-PP	IN	O	46	VMOD	O
O	O	1319	1322	170	170	B-NP	CD	O	53	NMOD	O
O	O	1323	1324	+	+	O	SYM	O	53	NMOD	O
O	O	1324	1325	/	/	O	SYM	O	53	NMOD	O
O	O	1325	1326	-	-	O	SYM	O	53	NMOD	O
O	O	1327	1328	8	8	B-NP	CD	O	53	NMOD	O
O	O	1328	1329	%	%	I-NP	NN	O	47	PMOD	O
O	O	1329	1330	.	.	O	.	O	20	P	O

O	O	1331	1339	Addition	Addition	B-NP	NN	O	8	SUB	O
O	O	1340	1342	of	of	B-PP	IN	O	1	NMOD	O
O	O	1343	1352	activated	activate	B-NP	VBN	B-cell_type	4	NMOD	B-cell_type
O	O	1353	1362	platelets	platelet	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	1363	1365	to	to	B-PP	TO	O	1	NMOD	O
O	O	1366	1374	adherent	adherent	B-NP	JJ	B-cell_type	7	NMOD	B-cell_type
O	O	1375	1384	monocytes	monocyte	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	1385	1388	had	have	B-VP	VBD	O	0	ROOT	O
O	O	1389	1390	a	a	B-NP	DT	O	11	NMOD	O
O	O	1391	1398	similar	similar	I-NP	JJ	O	11	NMOD	O
O	O	1399	1405	effect	effect	I-NP	NN	O	8	OBJ	O
O	O	1406	1409	and	and	O	CC	O	8	VMOD	O
O	O	1410	1413	was	be	B-VP	VBD	O	8	VMOD	O
O	O	1414	1424	associated	associate	I-VP	VBN	O	13	VC	O
O	O	1425	1429	with	with	B-PP	IN	O	14	VMOD	O
T13	B-Entity	1430	1437	nuclear	nuclear	B-NP	JJ	B-protein	21	NMOD	B-protein
T13	I-Entity	1438	1444	factor	factor	I-NP	NN	I-protein	21	NMOD	I-protein
T13	I-Entity	1444	1445	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T13	I-Entity	1445	1450	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T13	I-Entity	1451	1452	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	1453	1463	activation	activation	I-NP	NN	O	15	PMOD	O
O	O	1463	1464	.	.	O	.	O	8	P	O

O	O	1465	1475	Inhibition	Inhibition	B-NP	NN	O	10	SUB	O
O	O	1476	1478	of	of	B-PP	IN	O	1	NMOD	O
O	O	1479	1486	binding	binding	B-NP	NN	O	2	PMOD	O
O	O	1487	1489	by	by	B-PP	IN	O	1	NMOD	O
O	O	1490	1494	anti	anti	B-NP	AFX	O	9	NMOD	O
O	O	1494	1495	-	-	I-NP	HYPH	B-protein	9	NMOD	B-protein
T9	B-Protein	1495	1496	P	P	I-NP	NN	I-protein	9	NMOD	I-protein
T9	I-Protein	1497	1505	selectin	selectin	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	1506	1516	antibodies	antibody	I-NP	NNS	I-protein	4	PMOD	I-protein
O	O	1517	1524	reduced	reduce	B-VP	VBD	O	0	ROOT	O
O	O	1525	1528	the	the	B-NP	DT	O	12	NMOD	O
O	O	1529	1535	effect	effect	I-NP	NN	O	10	OBJ	O
O	O	1536	1538	of	of	B-PP	IN	O	12	NMOD	O
O	O	1539	1548	activated	activate	B-NP	VBN	B-cell_type	15	NMOD	B-cell_type
O	O	1549	1558	platelets	platelet	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	1559	1561	on	on	B-PP	IN	O	12	NMOD	O
O	O	1562	1570	cytokine	cytokine	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	1571	1581	production	production	I-NP	NN	O	16	PMOD	O
O	O	1581	1582	.	.	O	.	O	10	P	O

O	O	1583	1594	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	O
O	O	1594	1595	:	:	O	:	O	1	P	O
O	O	1596	1598	In	In	B-PP	IN	O	12	VMOD	O
O	O	1599	1607	patients	patient	B-NP	NNS	O	3	PMOD	O
O	O	1608	1612	with	with	B-PP	IN	O	4	NMOD	O
O	O	1613	1616	AMI	AMI	B-NP	NN	O	5	PMOD	O
O	O	1616	1617	,	,	O	,	O	12	P	O
O	O	1618	1627	leukocyte	leukocyte	B-NP	NN	B-cell_type	11	NMOD	B-cell_type
O	O	1627	1628	-	-	I-NP	HYPH	O	11	NMOD	O
O	O	1628	1636	platelet	platelet	I-NP	NN	O	11	NMOD	O
O	O	1637	1645	adhesion	adhesion	I-NP	NN	O	12	SUB	O
O	O	1646	1648	is	be	B-VP	VBZ	O	1	NMOD	O
O	O	1649	1658	increased	increase	I-VP	VBN	O	12	VC	O
O	O	1658	1659	.	.	O	.	O	1	P	O

O	O	1660	1667	Binding	Binding	B-NP	NN	O	5	SUB	O
O	O	1668	1670	of	of	B-PP	IN	O	1	NMOD	O
O	O	1671	1680	activated	activate	B-NP	VBN	B-cell_type	4	NMOD	B-cell_type
O	O	1681	1690	platelets	platelet	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	1691	1698	induces	induce	B-VP	VBZ	O	0	ROOT	O
T10	B-Protein	1699	1701	IL	IL	B-NP	NN	B-protein	9	NMOD	B-protein
T10	I-Protein	1701	1702	-	-	B-NP	HYPH	I-protein	8	P	I-protein
T10	I-Protein	1702	1703	1	1	I-NP	CD	I-protein	9	NMOD	I-protein
T10	I-Protein	1704	1708	beta	beta	B-NP	SYM	I-protein	12	NMOD	I-protein
O	O	1708	1709	,	,	O	,	O	12	P	O
T11	B-Protein	1710	1712	IL	IL	B-NP	NN	B-protein	12	NMOD	B-protein
T11	I-Protein	1712	1713	-	-	O	HYPH	I-protein	5	P	I-protein
T11	I-Protein	1713	1714	8	8	B-NP	CD	I-protein	5	OBJ	I-protein
O	O	1714	1715	,	,	O	,	O	17	P	O
O	O	1716	1719	and	and	O	CC	O	17	NMOD	O
T12	B-Protein	1720	1723	MCP	MCP	B-NP	NN	B-protein	17	NMOD	B-protein
T12	I-Protein	1723	1724	-	-	B-NP	HYPH	I-protein	5	VMOD	I-protein
T12	I-Protein	1724	1725	1	1	I-NP	CD	I-protein	17	NMOD	I-protein
O	O	1726	1728	in	in	B-PP	IN	O	5	VMOD	O
O	O	1729	1739	leukocytes	leukocyte	B-NP	NNS	B-cell_type	19	PMOD	B-cell_type
O	O	1739	1740	.	.	O	.	O	5	P	O

O	O	1741	1744	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	1745	1753	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	1754	1761	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1762	1766	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1767	1776	leukocyte	leukocyte	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	1776	1777	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	1777	1785	platelet	platelet	I-NP	NN	O	8	NMOD	O
O	O	1786	1794	adhesion	adhesion	I-NP	NN	O	9	SUB	O
O	O	1795	1806	contributes	contribute	B-VP	VBZ	O	4	SBAR	O
O	O	1807	1809	to	to	B-PP	TO	O	9	VMOD	O
O	O	1810	1813	the	the	B-NP	DT	O	12	NMOD	O
O	O	1814	1824	regulation	regulation	I-NP	NN	O	10	PMOD	O
O	O	1825	1827	of	of	B-PP	IN	O	12	NMOD	O
O	O	1828	1840	inflammatory	inflammatory	B-NP	JJ	O	15	NMOD	O
O	O	1841	1850	responses	response	I-NP	NNS	O	13	PMOD	O
O	O	1851	1853	in	in	B-PP	IN	O	12	NMOD	O
O	O	1854	1857	AMI	AMI	B-NP	NN	O	16	PMOD	O
O	O	1857	1858	.	.	O	.	O	3	P	O
